ClinicalTrials.gov
public full text
Public Domain
Clearance Mechanisms in Atypical Neurodegenerative Diseases
The project PeptiClear aims to investigate whether the blood-brain-barrier (BBB) and the glymphatic system are compromised in atypical neurodegenerative diseases, and whether Alzheimer´s disease (AD)-related copathology, vascular lesions or sleep disturbances modify the clinical picture or structural and/or functional features of the diseases.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD#903489
- Blood-brain barrier dysfunction as a physiological trigger of cellular senescence#1106851
- MRI detects blood-brain barrier alterations in a rat model of Alzheimer’s disease and lung infection#274370
- Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)#1033590
- Biomarker-based Trial of NPC-1 for Alzheimer's Pathology#897412
Record · ID 1421790
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive